31.29
price up icon2.22%   0.68
after-market 시간 외 거래: 31.29
loading

Alkermes Plc 주식(ALKS)의 최신 뉴스

pulisher
04:23 AM

Alkermes to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference | ALKS Stock News - GuruFocus

04:23 AM
pulisher
04:01 AM

Alkermes to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference - marketscreener.com

04:01 AM
pulisher
11:03 AM

Opioid Use Disorder Market Projected to Witness Massive GrowthIndivior PLC, Alkermes plc - openPR.com

11:03 AM
pulisher
07:00 AM

Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences - PR Newswire

07:00 AM
pulisher
May 31, 2025

Is There An Opportunity With Alkermes plc's (NASDAQ:ALKS) 48% Undervaluation? - simplywall.st

May 31, 2025
pulisher
May 31, 2025

Where are the Opportunities in (ALKS) - news.stocktradersdaily.com

May 31, 2025
pulisher
May 29, 2025

Alkermes (ALKS) to Present New Findings on ALKS 2680 at SLEEP 20 - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Alkermes (ALKS) to Present New Findings on ALKS 2680 at SLEEP 2025 | ALKS Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Alkermes to Present New Research Related to ALKS 2680 at SLEEP 2025 - PR Newswire

May 29, 2025
pulisher
May 29, 2025

Global Healthcare & Medical Tourism News - Medical Tourism Magazine

May 29, 2025
pulisher
May 28, 2025

Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) - Benzinga

May 28, 2025
pulisher
May 28, 2025

This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

May 28, 2025
pulisher
May 28, 2025

Needham Initiates Alkermes Public at Buy With $45 Price Target - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Needham's Positive Outlook on Alkermes (ALKS) with Promising Sal - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Needham Initiates Coverage on Alkermes (ALKS) with Buy Rating | ALKS Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Needham's Positive Outlook on Alkermes (ALKS) with Promising Sales Projections | ALKS Stock News - GuruFocus

May 28, 2025
pulisher
May 23, 2025

Controlled Release Drug Delivery Market Generated - openPR.com

May 23, 2025
pulisher
May 21, 2025

Alkermes Shareholders Approve Amendments at Annual Meeting - TipRanks

May 21, 2025
pulisher
May 20, 2025

(ALKS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

May 20, 2025
pulisher
May 20, 2025

Alkermes price target raised to $35 from $34 at BofA - MSN

May 20, 2025
pulisher
May 16, 2025

Nanotechnology Drug Delivery Market Generated Opportunities, - openPR.com

May 16, 2025
pulisher
May 15, 2025

Stifel maintains Alkermes stock Buy rating, $42 target By Investing.com - Investing.com Nigeria

May 15, 2025
pulisher
May 13, 2025

Drug Addiction Treatment Market Projected To Witness Massive - openPR.com

May 13, 2025
pulisher
May 12, 2025

Drug Abuse Treatment Market Grows Amid Rising Substance Abuse - openPR.com

May 12, 2025
pulisher
May 12, 2025

Cantor Fitzgerald maintains $43 target on Alkermes stock By Investing.com - Investing.com Nigeria

May 12, 2025
pulisher
May 12, 2025

Controlled Release Drug Delivery Market is in trends - openPR.com

May 12, 2025
pulisher
May 12, 2025

Alkermes plc Earnings Call Highlights Growth and R&D Progress - MSN

May 12, 2025
pulisher
May 10, 2025

When the Price of (ALKS) Talks, People Listen - news.stocktradersdaily.com

May 10, 2025
pulisher
May 03, 2025

Alkermes plc (ALKS): Among Billionaire Jim Simons’ RenTech’s Small-Cap Stock Picks with Huge Upside Potential - Insider Monkey

May 03, 2025
pulisher
May 03, 2025

Alkermes plc (NASDAQ:ALKS) Q1 2025 Earnings Call Transcript - Insider Monkey

May 03, 2025
pulisher
May 03, 2025

Alkermes has near-term catalyst with narcolepsy data, says H.C. Wainwright - TipRanks

May 03, 2025
pulisher
May 03, 2025

BlackRock, Inc. Reduces Stake in Alkermes PLC: A Detailed Analysis - GuruFocus

May 03, 2025
pulisher
May 02, 2025

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Alkermes plc To Contact The Firm - ACCESS Newswire

May 02, 2025
pulisher
May 02, 2025

RBC Capital Raises Price Target for Alkermes (ALKS) to $40 | ALKS Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Alkermes' Q1 Earnings and Revenues Fall Short of Estimates - Nasdaq

May 02, 2025
pulisher
May 02, 2025

Alkermes (ALKS) Reaffirms 2025 Financial Outlook and Awaits Key Trial Results | ALKS Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Alkermes (ALKS) Price Target Raised to $41 by Baird Analyst | AL - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Alkermes (ALKS) Price Target Raised to $41 by Baird Analyst | ALKS Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Baird Increases Price Target for Alkermes (ALKS) on Promising Ou - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Baird Increases Price Target for Alkermes (ALKS) on Promising Outlook | ALKS Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

RBC Raises Price Target on Alkermes to $40 From $39, Keeps Sector Perform Rating - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

Alkermes PLC (ALKS) Q1 2025 Earnings Call Highlights: Strong Proprietary Product Growth and ... - Yahoo

May 02, 2025
pulisher
May 02, 2025

Alkermes PLC (ALKS) Q1 2025 Earnings Call Highlights: Strong Pro - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Alkermes: Q1 Earnings Snapshot - MySA

May 02, 2025
pulisher
May 02, 2025

Alkermes plc Reports Q1 2025 Financial Results - TipRanks

May 02, 2025
pulisher
May 01, 2025

Alkermes Plc earnings missed by $0.18, revenue fell short of estimates - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

Alkermes: Label Expansion Of LYBALVI With Ongoing Pediatric Trial Possible (NASDAQ:ALKS) - Seeking Alpha

May 01, 2025
pulisher
May 01, 2025

Chondrosarcoma Market: Epidemiology, Therapies, Companies, - openPR.com

May 01, 2025
pulisher
May 01, 2025

Alkermes to Report First Quarter Financial Results on May 1, 2025 - PR Newswire UK

May 01, 2025
pulisher
May 01, 2025

Alkermes Q1 2025 Earnings Call Transcript - MarketBeat

May 01, 2025
pulisher
May 01, 2025

Here's What Key Metrics Tell Us About Alkermes (ALKS) Q1 Earnings - Yahoo Finance

May 01, 2025
pulisher
May 01, 2025

Alkermes Q1 Earnings, Revenue Decline - marketscreener.com

May 01, 2025
pulisher
May 01, 2025

Alkermes Plc reports results for the quarter ended March 31Earnings Summary - TradingView

May 01, 2025
pulisher
May 01, 2025

Alkermes PLC Q1 2025 Earnings: EPS of $0.13 Beats Estimate, Reve - GuruFocus

May 01, 2025
$8.69
price down icon 1.14%
drug_manufacturers_specialty_generic HCM
$13.60
price down icon 2.09%
drug_manufacturers_specialty_generic RDY
$14.74
price up icon 0.14%
$124.56
price up icon 1.25%
$325.48
price up icon 2.08%
$17.26
price up icon 2.86%
자본화:     |  볼륨(24시간):